Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$3.74 - $6.7 $60,214 - $107,870
-16,100 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$6.05 - $10.41 $417,450 - $718,290
-69,000 Reduced 81.08%
16,100 $101,000
Q2 2021

Aug 16, 2021

SELL
$6.66 - $10.92 $458,874 - $752,388
-68,900 Reduced 44.74%
85,100 $839,000
Q1 2021

May 18, 2021

BUY
$4.59 - $18.74 $706,860 - $2.89 Million
154,000 New
154,000 $1.44 Million

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $362M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.